Cancer hijack

July 19, 2013

Genetically unstable breast cancer cells appear to hijack a mechanism used by healthy stem cells to determine how they should develop into different tissues, according to new research.

The study sheds new light on the development of a sub-type of breast cancers that are particularly hard to treat, and suggests a dual-pronged attack could be effective against them.

The research was conducted by Dr Matt Smalley of the University's European Cancer Stem Cell Research Institute, at The Institute of Cancer Research, London.

Dr Smalley said: "Current theories suggest that there may be similarities between the behaviour of normal adult stem cells and cancer cells. By better understanding the biology of scientists can better understand the behaviour of cancer cells and identify new targets for therapy.

"The hijacked mechanism involves a protein called Aurora Kinase, an enzyme which is essential for cell division in normal cells. It is also activated in genetically unstable cancer cells where it prevents the genetic losses and gains from becoming so extreme that the cell can no longer survive.

"If this function could be prevented, cancer cells would literally tear themselves apart."

Professor Jane Visvader of the Walter and Eliza Hall Institute of Medical Research Stem Cells and Cancer division in Victoria, Australia, said:

"The newly discovered link between Aurora kinase and the Notch pathway provides an important mechanism for regulating cell-fate decisions by mammary stem cells and highlights the importance of their interaction with the microenvironment.

"These findings also have significant implications for the development of novel therapeutic strategies for the aggressive basal-like subtype of , in which these pathways are often deregulated."

Explore further: Tools for better understanding breast cancer stem cells

More information: Cell Reports, Volume 4, Issue 1, 110-123, 27 June 2013 DOI 10.1016/j.celrep.2013.05.044

Related Stories

Tools for better understanding breast cancer stem cells

June 4, 2013
A joint project between the Griffith University and the UQ Centre for clinical Research (UQCCR) has characterised an in vitro model that allows further studies on the breast cancer biology.

Researchers discover molecule that drives aggressive breast cancer

July 1, 2013
(Medical Xpress)—Recent studies by researchers at Thomas Jefferson University's Kimmel Cancer Center have shown a gene known to coordinate initial development of the eye (EYA1) is a powerful breast tumor promoter in mice. ...

Scientists identify gene that controls aggressiveness in breast cancer cells

July 3, 2013
In a discovery that sheds new light on the aggressiveness of certain breast cancers, Whitehead Institute researchers have identified a transcription factor, known as ZEB1, that is capable of converting non-aggressive basal-type ...

Researchers discover how a mutated protein outwits evolution and fuels leukemia

June 20, 2013
Scientists have discovered the survival secret to a genetic mutation that stokes leukemia cells, solving an evolutionary riddle and paving the way to a highly targeted therapy for leukemia. In a paper published today in Cell, ...

Recommended for you

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Lung cancer triggers pulmonary hypertension

November 17, 2017
Shortness of breath and respiratory distress often increase the suffering of advanced-stage lung cancer patients. These symptoms can be triggered by pulmonary hypertension, as scientists at the Max Planck Institute for Heart ...

Researchers discover an Achilles heel in a lethal leukemia

November 16, 2017
Researchers have discovered how a linkage between two proteins in acute myeloid leukemia enables cancer cells to resist chemotherapy and showed that disrupting the linkage could render the cells vulnerable to treatment. St. ...

Computer program finds new uses for old drugs

November 16, 2017
Researchers at the Case Comprehensive Cancer Center at Case Western Reserve University School of Medicine have developed a computer program to find new indications for old drugs. The computer program, called DrugPredict, ...

Pharmacoscopy improves therapy for relapsed blood cancer in a first clinical trial

November 16, 2017
Researchers at CeMM and the Medical University of Vienna presented a preliminary report in The Lancet Hematology on the clinical impact of an integrated ex vivo approach called pharmacoscopy. The procedures measure single-cell ...

Wider sampling of tumor tissues may guide drug choice, improve outcomes

November 15, 2017
A new study focused on describing genetic variations within a primary tumor, differences between the primary and a metastatic branch of that tumor, and additional diversity found in tumor DNA in the blood stream could help ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.